Carregant...
Advances in targeted therapy for acute myeloid leukemia
Acute myeloid leukemia (AML) is a clonal malignancy characterized by genetic heterogeneity due to recurrent gene mutations. Treatment with cytotoxic chemotherapy has been the standard of care for more than half of a century. Although much progress has been made toward improving treatment related mor...
Guardat en:
| Publicat a: | Biomark Res |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7238648/ https://ncbi.nlm.nih.gov/pubmed/32477567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00196-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|